BofA lowered the firm’s price target on Carlyle (CG) to $50 from $56 and keeps an Underperform rating on the shares. The firm expects “good” fundraising, in-line investing activity, soft returns and flat realizations when Carlyle reports Q3 results, the analyst tells investors in a preview for the asset manager group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CG:
- Carlyle Group’s Growth Potential and Market Outperformance: A BMO Capital Analyst Recommendation
- Carlyle initiated with an Outperform at BMO Capital
- Carlyle Group: Hold Rating Amid Balanced Growth Prospects and Valuation Concerns
- Private Markets: Ring maker Oura to become $11B company
- Medline mulls $5B IPO filing as soon as next month, Bloomberg reports